Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrew Jang"'
Autor:
Andrew Jang BHSc, Chris Brown MBiostat, Gillian Lamoury MBBS, Marita Morgia MBBS, Frances Boyle MBBS, PhD, Isobel Marr MD, Stephen Clarke MBBS, PhD, Michael Back MBBS, PhD, Byeongsang Oh Oh, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Background Several studies have identified fatigue as one of the major symptoms experienced during and after cancer treatment. However, there are limited options to manage cancer related fatigue (CRF) with pharmacological interventions. Several acupu
Externí odkaz:
https://doaj.org/article/7c2e97e838a3412fa820b3f3c559786b
Autor:
Andrew Jang, Me-riong Kim, Seung Min Kathy Lee, In-Hyuk Ha, Ji-Yun Shin, Rance McClain, Jinho Lee
Publikováno v:
Medical Teacher. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e52e8c2f19eaf13b02b39ca4c2b4a1c9
https://doi.org/10.1080/0142159x.2023.2183787
https://doi.org/10.1080/0142159x.2023.2183787
Autor:
Shweta Singh, Laura Serwer, Amy DuPage, Kristi Elkins, Niharika Chauhan, Matthew Ravn, Fritz Buchanan, Leyu Wang, Michael Krimm, Ken Wong, Jason Sagert, Kimberly Tipton, Stephen J. Moore, Yuanhui Huang, Andrew Jang, Eric Ureno, Adam Miller, Sarah Patrick, Shanti Duvur, Shouchun Liu, Olga Vasiljeva, Yingchun Li, Tracy Henriques, Ilaria Badagnani, Shawn Jeffries, Siew Schleyer, Rob Leanna, Claus Krebber, Sridhar Viswanathan, Luc Desnoyers, Jonathan Terrett, Marcia Belvin, Susan Morgan-Lappe, W. Michael Kavanaugh, Jennifer Richardson
Publikováno v:
Molecular Cancer Therapeutics. 21:1326-1336
Probody therapeutics (Pb-Txs) are conditionally activated antibody–drug conjugates (ADCs) designed to remain inactive until proteolytically activated in the tumor microenvironment, enabling safer targeting of antigens expressed in both tumor and no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb073726d937f7e11b7d94e91eed5013
https://doi.org/10.1158/1535-7163.mct-21-0193
https://doi.org/10.1158/1535-7163.mct-21-0193
Autor:
Jennifer Richardson, W. Michael Kavanaugh, Susan Morgan-Lappe, Marcia Belvin, Jonathan Terrett, Luc Desnoyers, Sridhar Viswanathan, Claus Krebber, Rob Leanna, Siew Schleyer, Shawn Jeffries, Ilaria Badagnani, Tracy Henriques, Yingchun Li, Olga Vasiljeva, Shouchun Liu, Shanti Duvur, Sarah Patrick, Adam Miller, Eric Ureno, Andrew Jang, Yuanhui Huang, Stephen J. Moore, Kimberly Tipton, Jason Sagert, Ken Wong, Michael Krimm, Leyu Wang, Fritz Buchanan, Matthew Ravn, Niharika Chauhan, Kristi Elkins, Amy DuPage, Laura Serwer, Shweta Singh
Supplementary Data from Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734c4baf0734abf8c7e252b8e10c6fd0
https://doi.org/10.1158/1535-7163.22523304.v1
https://doi.org/10.1158/1535-7163.22523304.v1
Autor:
Andrew Jang, Kimberly Ann Tipton, Chihunt Wong, Bryan Irving, Olga Vasiljeva, Margaret Nguyen, Victoria Singson, Vangipuram Rangan, W. Michael Kavanaugh, James William West, Jason Gary Sagert, Michael Krimm, Chanty Chan, Jennifer Richardson, Li Mei, Madan M. Paidhungat, Ruth Villanueva, Jennifer Razo, Hikmat Assi, Linnea Diep, Marcia Belvin, Shouchun Liu, Bruce Howng, Ken Wong, Nicole Lapuyade, Dylan Daniel
Publikováno v:
Cancer Immunology Research. 9:1451-1464
Immune-checkpoint blockade has revolutionized cancer treatment. However, most patients do not respond to single-agent therapy. Combining checkpoint inhibitors with other immune-stimulating agents increases both efficacy and toxicity due to systemic T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded81d238596ec1daa607db4fe49c6fc
https://doi.org/10.1158/2326-6066.cir-21-0031
https://doi.org/10.1158/2326-6066.cir-21-0031
Autor:
Frances M. Boyle, Michael Back, Isobel Marr, Chris Brown, Byeongsang Oh, Andrew Jang, Marita Morgia, Gillian Lamoury, Stephen Clarke
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Integrative Cancer Therapies
Integrative Cancer Therapies
Background Several studies have identified fatigue as one of the major symptoms experienced during and after cancer treatment. However, there are limited options to manage cancer related fatigue (CRF) with pharmacological interventions. Several acupu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4e17053d7d8b723894bf108be05522
https://doi.org/10.1177/1534735420949679
https://doi.org/10.1177/1534735420949679
Autor:
Yuanhui Huang, Shouchun Liu, Adam Miller, Serwer Laura Patterson, Jennifer Richardson, Matthew M. Ravn, Shweta Singh, Michael Krimm, Michael P. Kavanaugh, Niharika Chauhan, Badagnani Ilaria, Andrew Jang, Rob Leanna, Ken Wong, Sarah Patrick, Claus M. Krebber, Henriques Tracy, Fritz G. Buchanan, Sridhar Viswanathan, Shanti Duvur, Eric Ureno, Amy DuPage, Susan Morgan-Lappe
Publikováno v:
Molecular Cancer Therapeutics. 17:B116-B116
ProbodyTM therapeutics are antibody prodrugs designed to remain largely inactive until proteolytically activated in the tumor microenvironment (TME), potentially enabling the safer targeting of antigens that are highly expressed in both tumor and nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a45c41479baf9927bb2e03c3e55d52c3
https://doi.org/10.1158/1535-7163.targ-17-b116
https://doi.org/10.1158/1535-7163.targ-17-b116
Autor:
Luc Desnoyers, Yuanhui Huang, Andrew Jang, Elizabeth Menendez, Jason Gary Sagert, Shouchun Liu, Eric Brecht, Olga Vasiljeva, Margaret Nguyen, Nicole Lapuyade, James W. West, Michael Krimm, Annie Yang Weaver, Jeanne Grace Flandez, Stephen R. Moore, Judi Ford, W. Michael Kavanaugh, Linnea Diep, Tereza Sputova, Jonathan A. Terrett, Shweta Singh, Amy DuPage, Jennifer Richardson
Publikováno v:
Molecular Cancer Therapeutics. 14:C165-C165
Antibody drug conjugates (ADCs) have shown their greatest clinical utility when targeting antigens expressed at very high levels on cancer cells that have coincidentally lower expression in normal tissues. This is exemplified by the approvals of tras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dfa74c2d7feb91893fa08e253ae6595
https://doi.org/10.1158/1535-7163.targ-15-c165
https://doi.org/10.1158/1535-7163.targ-15-c165